Bibb Lorin A, Winter Randi P, Leicht Stuart S
Dermatology, East Tennessee State University Quillen College of Medicine, Johnson City, USA.
Cureus. 2018 Oct 27;10(10):e3506. doi: 10.7759/cureus.3506.
Erythromelalgia is a neurovascular disorder which causes pain, swelling, erythema, and warmth of the distal extremities. Primary disease is due to a genetic mutation in the gene, but secondary erythromelalgia can be the consequence of a variety of underlying etiologies, including drug and toxin exposures. The disease is rare, occurring in only 1.3 out of every 100,000 in the United States, and symptoms can vary significantly in severity and presentation. Therefore, it can be difficult to recognize the disorder, identify the source, and promptly treat the condition. We report a reversible cause of erythromelalgia induced by the use of oral cyclosporine. This correlation is poorly documented in literature, with limited accounts identifying an association between erythromelalgia and cyclosporine. As drug-induced erythromelalgia represents a reversible cause of disease, physicians should obtain a detailed medication history during the diagnostic workup, specifically inquiring about the use of cyclosporine.
红斑性肢痛症是一种神经血管疾病,可导致远端肢体疼痛、肿胀、红斑和发热。原发性疾病是由该基因的基因突变引起的,但继发性红斑性肢痛症可能是多种潜在病因的结果,包括药物和毒素暴露。这种疾病很罕见,在美国每10万人中仅有1.3人发病,症状的严重程度和表现差异很大。因此,识别这种疾病、确定病因并及时治疗可能很困难。我们报告了一例因使用口服环孢素引起的红斑性肢痛症的可逆病因。这种关联在文献中记载较少,仅有有限的报道指出红斑性肢痛症与环孢素之间存在关联。由于药物性红斑性肢痛症是一种可逆的病因,医生在诊断检查过程中应获取详细的用药史,特别要询问环孢素的使用情况。